Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-DLL3 Antibody (4Q855)
😃Good
Catalog No. TMAH-00351
Alias δ3, SCDO1δ3, SCDO1delta3, SCDO1, Pudgy, DLL3, Delta3
Anti-DLL3 Antibody (4Q855) is an antibody targeting DLL3. Anti-DLL3 Antibody (4Q855) can be used in ELISA,FCM.
Anti-DLL3 Antibody (4Q855)
Anti-DLL3 Antibody (4Q855)
😃Good
Catalog No. TMAH-00351Alias δ3, SCDO1δ3, SCDO1delta3, SCDO1, Pudgy, DLL3, Delta3
Anti-DLL3 Antibody (4Q855) is an antibody targeting DLL3. Anti-DLL3 Antibody (4Q855) can be used in ELISA,FCM.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 μL | $209 | 7-10 days | 7-10 days | |
| 100 μL | $347 | 7-10 days | 7-10 days |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Anti-DLL3 Antibody (4Q855) is an antibody targeting DLL3. Anti-DLL3 Antibody (4Q855) can be used in ELISA,FCM. |
| Synonyms | δ3, SCDO1δ3, SCDO1delta3, SCDO1, Pudgy, DLL3, Delta3 |
| Ig Type | Human IgG1 |
| Clone | 4Q855 |
| Reactivity | Human |
| Verified Activity | 1. Untransfected HEK293 cells surface (green line) and transfected Human DLL3 HEK293 stable cells surface (red line) were stained with anti-DLL3 antibody (rovalpituzumab-like) (2µl/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG1 Fc antibody and analyzed with flow cytometry. 2. The Binding Activity of DLL3 with Anti-DLL3 Recombinant Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized DLL3 at 2 μg/mL can bind Anti-DLL3 Recombinant Antibody (TMAH-00351), the EC50 is 1.625-2.702 ng/mL. 3. The Binding Activity of DLL3 with Anti-DLL3 Recombinant Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized DLL3 at 2 μg/mL can bind Anti-DLL3 Recombinant Antibody (TMAH-00351), the EC50 is 1.102-1.707 ng/mL. 4. The purity of DLL3 was greater than 95% as determined by SEC-HPLC |
| Application | |
| Recommended Dose | FCM:1:50-1:200. |
| Antibody Type | Monoclonal |
| Subcellular Localization | Membrane; Single-pass type I membrane protein. |
| Construction | Recombinant Antibody |
| Purification | Affinity-chromatography |
| Appearance | Liquid |
| Formulation | Preservative: 0.03% Proclin 300. Constituents: 50% Glycerol, 0.01M PBS, PH 7.4. |
| Research Background | Inhibits primary neurogenesis. May be required to divert neurons along a specific differentiation pathway. Plays a role in the formation of somite boundaries during segmentation of the paraxial mesoderm. |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein: Human DLL3 Protein |
| Antigen Species | Human |
| Gene Name | DLL3 |
| Gene ID | |
| Uniprot ID | |
| Biology Area | Epigenetics and Nuclear Signaling, Neuroscience, Cell biology, Developmental biology |
Stability & Storage
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-DLL3 Antibody (4Q855) | purchase Anti-DLL3 Antibody (4Q855) | Anti-DLL3 Antibody (4Q855) cost | order Anti-DLL3 Antibody (4Q855)
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.